Inspire Medical Systems Inc
NYSE:INSP
Intrinsic Value
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. [ Read More ]
The intrinsic value of one
INSP
stock under the Base Case scenario is
73.61
USD.
Compared to the current market price of 229.22 USD,
Inspire Medical Systems Inc
is
Overvalued by 68%.
INSP's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
INSP or that its price is influenced by factors unrelated to fundamentals.
Inspire Medical Systems Inc's market capitalization is 6.8B USD.
INSP stock price is 229.22 USD.
INSP stock (73.61 USD) is 68% less than its price (229.22 USD).
INSP stock (111.78 USD) is 51% less than its price (229.22 USD). Open Relative Valuation
INSP has upside potential of 13% compared to the average analyst price target.
Open Wall St Estimates
INSP's ROE (Return on Equity) for the past 12 months is negative and is equal to -4%.
INSP's Revenue has grown by an exceptional 53% over the past 12 months.
INSP's Revenue is forecast to grow at a rate of 23% per year over the next 3 years.
INSP's ROE (Return on Equity) has significantly increased in the last 3 years from -33% to -4%, and is approaching profitability.
INSP's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -178% to -32%, and is approaching profitability.
INSP has negative Operating Income for the last twelve months.
INSP has negative Net Income for the last twelve months.
INSP's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -32%.
INSP has positive Gross Profit for the last twelve months.
INSP has positive Free Cash Flow for the last twelve months.
INSP's Revenue has been growing by an exceptional 76% per year for the last 3 years.
INSP has negative three-year average ROE (Return on Equity): -17%. The company is not efficient at transforming stockholders' equity into net income.
INSP has negative three-year average ROIC (Return on Invested Capital): -85%. The company is not efficient at using invested capital to generate operating income.
INSP's short-term assets (594m USD) exceed its short-term liabilties (78m USD).
INSP's long-term assets (677m USD) exceed its long-term liabilties (104m USD).
INSP's D/E (Debt to Equity) is very low and is equal to 0.
INSP's Altman Z-Score is very high and is equal to 34.7.
Valuation Backtest
Inspire Medical Systems Inc
Run backtest to discover the historical profit from buying and selling
INSP
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Inspire Medical Systems Inc
Balance Sheet Decomposition
Inspire Medical Systems Inc
| Current Assets | 593.7m |
| Cash & Short-Term Investments | 460.4m |
| Receivables | 89.9m |
| Other Current Assets | 43.5m |
| Non-Current Assets | 83.1m |
| Long-Term Investments | 9.1m |
| PP&E | 62.7m |
| Other Non-Current Assets | 11.3m |
| Current Liabilities | 78.1m |
| Accounts Payable | 38.8m |
| Accrued Liabilities | 39.3m |
| Non-Current Liabilities | 26.2m |
| Other Non-Current Liabilities | 26.2m |
Earnings Waterfall
Inspire Medical Systems Inc
|
Revenue
|
624.8m
USD
|
|
Cost of Revenue
|
-96.6m
USD
|
|
Gross Profit
|
528.2m
USD
|
|
Operating Expenses
|
-568.5m
USD
|
|
Operating Income
|
-40.3m
USD
|
|
Other Expenses
|
19.1m
USD
|
|
Net Income
|
-21.2m
USD
|
Free Cash Flow Analysis
Inspire Medical Systems Inc
What is Free Cash Flow?
INSP Profitability Score
Profitability Due Diligence
Inspire Medical Systems Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Inspire Medical Systems Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
INSP Solvency Score
Solvency Due Diligence
Inspire Medical Systems Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Inspire Medical Systems Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INSP Price Targets Summary
Inspire Medical Systems Inc
According to Wall Street analysts, the average 1-year price target for
INSP
is 257.92 USD
with a low forecast of 188.87 USD and a high forecast of 294 USD.
Ownership
INSP Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
INSP Price
Inspire Medical Systems Inc
| Average Annual Return | 59.51% |
| Standard Deviation of Annual Returns | 60.5% |
| Max Drawdown | -62% |
| Market Capitalization | 6.8B USD |
| Shares Outstanding | 30 300 000 |
| Percentage of Shares Shorted | 7.86% |
Company Profile
Inspire Medical Systems Inc
Country
Industry
Market Cap
Dividend Yield
Description
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 485 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The obstructive sleep apnea device that treats the root cause of sleep apnea by working inside the body with the patient’s natural breathing process. The firm has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its system to the hospitals and ambulatory surgery centers (ASCs) in the United States and in select countries in Europe through a direct sales organization.
Contact
IPO
Employees
Officers
The intrinsic value of one
INSP
stock under the Base Case scenario is
73.61
USD.
Compared to the current market price of 229.22 USD,
Inspire Medical Systems Inc
is
Overvalued by 68%.
You don't have any saved screeners yet
